Modified Two-Stage Exchange for MRSA Periprosthetic Joint Infection in Total Knee Arthroplasty: Case Report
Abstract
Periprosthetic joint infection (PJI) of the knee is a catastrophic complication that occurs in 1-2 % of patients after total knee arthroplasty. As the number of primary knee arthroplasty procedures increases, thus will the number of periprosthetic infections continues to be a major challenge with a significant financial burden and physical and psychological morbidity for patients. This report presents a case of MRSA Periprosthetic joint infection in TKA with a two-stage exchange as a treatment. A 79-year-old woman had a painful, swollen knee with a sinus tract with purulent discharge at her left knee. The KSS Knee Score was 25, and the Function Score was 15. According to the findings, the patient was diagnosed with Periprosthetic Joint Infection by the Modified MSIS criteria and underwent a two-stage revision surgery with rifampicin and ciprofloxacin antibiotic administration. PJI is a rare complication, with more than 50% of the cases caused by gram-positive cocci, Staphylococcus coagulase-negative, and Staphylococcus aureus. The treatment of PJI must be tailored according to the patient's clinical characteristics. Prosthesis exchange in one or two stages is the first choice of procedure. Two-stage revision surgery for knee PJI with dual antibiotics of rifampicin and ciprofloxacin is adequate to control infection and reinfection in a one-year follow-up.
Keywords
Full Text:
PDFReferences
Parvizi J, Tan TL, Goswami K, et al. The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria. J Arthroplasty. 2018;33(5):1309-1314.e2. doi:10.1016/j.arth.2018.02.078
de Carvalho Júnior LH, Temponi EF, Badet R. Infection after total knee replacement: Diagnosis and treatment. Revista Brasileira de Ortopedia (English Edition). 2013;48(5):389–96.
Argenson JN, Arndt M, Babis G, et al. Hip and Knee Section, Treatment, Debridement and Retention of Implant: Proceedings of International Consensus on Orthopedic Infections. J Arthroplasty. 2019;34(2S):S399-S419. doi:10.1016/j.arth.2018.09.025
Leung F, Richards CJ, Garbuz DS, Masri BA, Duncan CP. Two-stage total hip arthroplasty: how often does it control methicillin-resistant infection?. Clin Orthop Relat Res. 2011;469:1009–15
Santoso A, Yoon TR, Park KS, et al. The Results of Two-stage Revision for Methicillin-resistant Periprosthetic Joint Infection (PJI) of the Hip. Malays Orthop J. 2020;14(1):18-23. doi:10.5704/MOJ.2003.003
Hwang BH, Yoon JY, Nam CH, et al. Fungal peri-prosthetic joint infection after primary total knee replacement. J Bone Joint Surg Br. 2012;94(5):656-659. doi:10.1302/0301-620X.94B5.28125
Fazly Bazzaz BS, et al. Antibacterial efficacy of rifampin loaded solid lipid nanoparticles against Staphylococcus epidermidis biofilm. Microb Pathog. 2016;93:137–144
Senneville E, et al. outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus. Clin Infect Dis. 2011;53(4):334–340
Karlsen ØE, Borgen P, Bragnes B, et al. Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial. J Orthop Surg Res. 2020;15(1):365. Published 2020 Aug 28. doi:10.1186/s13018-020-01877-2
Holmberg A, et al. 75% success rate after open debridement, exchange of tibial insert, and antibiotics in knee prosthetic joint infections. Acta Orthop. 2015;86(4):457–462.
DOI: https://doi.org/10.46355/hipknee.v4i1.149
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The Knee and Hip Journal has been indexed and abstracted in the following databases: